J.P. Maffrand

55 papers receiving 3.8k citations

J.P. Maffrand's Hit Papers

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells 2003 · 522 citations
5220+12+24Years since publication2505007501000

Peers

J.P. Maffrand
Comparison fields: 5 of 115
  • Internal Medicine 243
  • Pharmacology 884
  • Endocrine and Autonomic Systems 333
  • Physiology 214
  • Cardiology and Cardiovascular Medicine 840
Replace A.G. Herman with:
A.G. Herman Belgium
Martine Tencé France
Dennis B. McNamara United States
Jun Ogata Japan
Tsunehiko Kuzuya Japan
B.J.R. Whittle United Kingdom
Takao Urabe Japan
Klaus Scholich Germany
Jens Schlossmann Germany
Michael J. Katovich United States
J.P. Maffrand relative to A.G. Herman Belgium A.G. Herman's profile →
Citations per field
00.5×6.6×
A.G. Herman · 1×
Citations per year

Countries citing papers authored by J.P. Maffrand

Since Specialization
Citations

This map shows the geographic impact of J.P. Maffrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Maffrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Maffrand more than expected).

Fields of papers citing papers by J.P. Maffrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Maffrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Maffrand. The network helps show where J.P. Maffrand may publish in the future.

Co-authors

The 25 scholars most cited alongside J.P. Maffrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.P. Maffrand Line = papers co-authored together J.P. Maffrand links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chelerythrine is a potent and specific inhibitor of protein kinase C
Hit paper breakdown →
19901148
2
The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells
Hit paper breakdown →
2003522
3 1993251
4 1995173
5 1998134
6 2007108
7 1994104
8 199193
9 199292
10 200289
11 199180
12 198880
13 198772
14 198966
15 199060
16 199548
17 199547
18 200145
19 198745
20 199643

About J.P. Maffrand

J.P. Maffrand is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Hematology, Cellular and Molecular Neuroscience and Surgery, having authored 56 papers that have together received 4.0k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (8 papers), Neuroendocrine regulation and behavior (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Platelet Disorders and Treatments (5 papers) and Electrolyte and hormonal disorders (5 papers). The work is most often cited by research in Internal Medicine (243 citations), Pharmacology (884 citations), Endocrine and Autonomic Systems (333 citations), Physiology (214 citations) and Cardiology and Cardiovascular Medicine (840 citations). J.P. Maffrand has collaborated with scholars based in France, Italy and United Kingdom. Frequent co-authors include Jean‐Marc Herbert, Jean‐Michel Augereau, J. Gleye, G. Le Fur, A. Bernat, Philippe Soubrié, M. Bensaïd, Magali Gary‐Bobo, Florence Oury-Donat and Pierre Savi. Their work appears in journals such as Thrombosis and Haemostasis, Thrombosis Research, Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact